VG
Vishal Gupta
About Vishal Gupta
Data last updated:
Vishal Gupta has 21 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Oshino Drugs Private Limited and Sylus Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Oshino Drugs Private Limited at ₹15.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2005 | 2000 | ₹15.75 Cr (FY 2025) | Active | |
| Director | 23 Jan 2026 | 2026 | – | Active | |
| Designated Partner | 16 Jun 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishal Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishal Gupta
Vishal Gupta has 21 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Oshino Drugs Private Limited and Sylus Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Oshino Drugs Private Limited at ₹15.75 Cr (FY 2025).
Vishal Gupta is associated with 3 companies as Director and Designated Partner, including Oshino Drugs Private Limited (₹15.75 Cr), Sylus Pharma India Private Limited, Gupta Square Trading Llp.
Vishal Gupta has expertise in General Business.
Vishal Gupta has 21 years in corporate governance.
By reported revenue, the largest current company of Vishal Gupta is Oshino Drugs Private Limited, with revenue of ₹15.75 Cr (FY 2025).
Vishal Gupta currently holds positions at 3 companies: Oshino Drugs Private Limited (₹15.75 Cr), Sylus Pharma India Private Limited, Gupta Square Trading Llp.